Retham Technologies

United States
Wauwatosa, Wisconsin, United States

Company profile

Retham Technologies company profile

Retham Technologies is a biotech business that enables HIT testing to diagnose heparin-induced thrombocytopenia. They develop an IVD assay for patient HIT diagnosis is expected to facilitate timely and appropriate therapy.

Business identity

Contact email
[email protected]
Phone number
(347) 346-3423
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $100,000 / 2022-12-14
Investors
1
Lead investors
1
Founders
1
Articles
4

Founders and investors

Founders

Anand Padmanabhan

Lead investors

SBIR Advance

Investors

SBIR Advance